Phase 2 ARCHER Data Support Therapeutic Potential for ANX007 to Preserve Vision in Patients who have Dry Age-related Macular Degeneration (AMD) with Geographic Atrophy (GA) ...

The food company behind popular brands like Jimmy Dean and Hillshire Farm will eliminate all petroleum-based synthetic dyes ...

If phase 3 trials of MM120 (lysergide d-tartrate) for anxiety and depression are successful, could the LSD-based drug become ...

Novo Nordisk lowered its full-year guidance as copycat versions of its blockbuster weight-loss and diabetes drugs in the U.S.

A new medication that combines an already approved drug with a new unapproved one has been shown to cut the level of LDL, or ...

The slow loss of memory, thinking, and independence that defines Alzheimer’s disease continues to affect millions worldwide.

This is a mistake. GLP-1s appear to modify addictive brain pathways that are activated by ultraformulated foods, helping ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

Now is the time for the biotechnology sector to ask for big changes to the FDA, NIH, reimbursement, intellectual property and ...

A coalition of 20 attorneys general are suing to block what they say is the Trump administration's “dangerous dismantling” of the federal health agency, adding that recent actions endanger programs, ...

The FDA has released its report on the 2023 actions of its Core Outbreak Response and Evaluation network. The network’s ...